Reumatoloxía

2024

1. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry

   Journal of Clinical Medicine, Vol. 13, Núm. 20

2. A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome

   Arthritis and Rheumatology, Vol. 76, Núm. 11, pp. 1623-1634

3. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

   Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287

4. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

   Frontiers in Pharmacology, Vol. 15

5. Anti-Inflammatory Activity of APPA (Apocynin and Paeonol) in Human Articular Chondrocytes

   Pharmaceuticals, Vol. 17, Núm. 1

6. Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease

   Antioxidants, Vol. 13, Núm. 10

7. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

   RMD Open, Vol. 10, Núm. 3

8. Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease

   Expert Review of Clinical Immunology, Vol. 20, Núm. 9, pp. 1089-1100

9. Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort

   Skeletal Radiology, Vol. 53, Núm. 11, pp. 2409-2416

10. Childhood-Onset Non-Infectious Uveitis in the “Biologic Era”. Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings

    Ocular Immunology and Inflammation, Vol. 32, Núm. 9, pp. 2159-2169

11. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

12. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

    Seminars in Arthritis and Rheumatism, Vol. 65

13. Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion

    Rheumatology International, Vol. 44, Núm. 11, pp. 2327-2336

14. Delphi consensus on the use of telemedicine in rheumatology: RESULTAR study

    Reumatologia Clinica, Vol. 20, Núm. 5, pp. 254-262

15. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

    Rheumatology International, Vol. 44, Núm. 11, pp. 2445-2455

16. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

17. Early identification of golimumab-treated patients with higher likelihood of long-term retention

    Frontiers in Immunology, Vol. 15

18. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

    European Journal of Internal Medicine, Vol. 129, pp. 78-86

19. Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting

    Vaccines, Vol. 12, Núm. 6

20. Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature

    Arthritis Research and Therapy, Vol. 26, Núm. 1